| Report Title | Price | Action |
|---|---|---|
| B Lymphocyte Antigen CD20 (B Lymphocyte Surface Antigen B1 or Bp35 or Leukocyte Surface Antigen Leu 16 or Membrane Spanning 4 Domains Subfamily A Member 1 or CD20 or MS4A1) - Drugs in Development, 2021
B Lymphocyte Antigen CD20 (B Lymphocyte Surface Antigen B1 or Bp35 or Leukocyte Surface Antigen Leu 16 or Membrane Spanning 4 Domains Subfamily A Memb...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Prostaglandin G/H Synthase 2 (Cyclooxygenase 2 or COX2 or Prostaglandin Endoperoxide Synthase 2 or PHS II or Prostaglandin H2 Synthase 2 or PTGS2 or EC 1.14.99.1) - Drugs in Development, 2021
Prostaglandin G/H Synthase 2 (Cyclooxygenase 2 or COX2 or Prostaglandin Endoperoxide Synthase 2 or PHS II or Prostaglandin H2 Synthase 2 or PTGS2 or E...
Published: Apr-2021 | No. of Pages: 230
|
$ 3500 | |
| Interleukin 23 (IL23) - Drugs in Development, 2021
Interleukin 23 (IL23) - Drugs in Development, 2021 Summary Interleukin 23 (IL23) - Drugs in Development, 2021 provides in depth analysis on Interleu...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Interleukin 1 Beta (IL 1 Beta or Catabolin or IL1B) - Drugs in Development, 2021
Interleukin 1 Beta (IL 1 Beta or Catabolin or IL1B) - Drugs in Development, 2021 Summary Interleukin 1 Beta (IL 1 Beta or Catabolin or IL1B) - Drugs...
Published: Apr-2021 | No. of Pages: 60
|
$ 3000 | |
| Flavivirus Infections (Infectious Disease) - Drugs in Development, 2021
Flavivirus Infections (Infectious Disease) - Drugs in Development, 2021 Summary Flavivirus Infections (Infectious Disease) - Drugs in Development, 2...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Relapsed Acute Myeloid Leukemia (Oncology) - Drugs in Development, 2021
Relapsed Acute Myeloid Leukemia (Oncology) - Drugs in Development, 2021 Summary Relapsed Acute Myeloid Leukemia (Oncology) - Drugs in Development, 2...
Published: Apr-2021 | No. of Pages: 425
|
$ 2500 | |
| Beta Galactosidase (Acid Beta Galactosidase or Lactase or Elastin Receptor 1 or GLB1 or EC 3.2.1.23) - Drugs in Development, 2021
Beta Galactosidase (Acid Beta Galactosidase or Lactase or Elastin Receptor 1 or GLB1 or EC 3.2.1.23) - Drugs in Development, 2021 Summary Beta Galac...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Glucagon Like Peptide 1 Receptor (GLP1R) - Drugs in Development, 2021
Glucagon Like Peptide 1 Receptor (GLP1R) - Drugs in Development, 2021 Summary Glucagon Like Peptide 1 Receptor (GLP1R) - Drugs in Development, 2021 ...
Published: Apr-2021 | No. of Pages: 270
|
$ 3500 | |
| Interleukin 23 Receptor (IL23R) - Drugs in Development, 2021
Interleukin 23 Receptor (IL23R) - Drugs in Development, 2021 Summary Interleukin 23 Receptor (IL23R) - Drugs in Development, 2021 provides in depth ...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Interferon Alpha (IFNA) - Drugs in Development, 2021
Interferon Alpha (IFNA) - Drugs in Development, 2021 Summary Interferon Alpha (IFNA) - Drugs in Development, 2021 provides in depth analysis on Inte...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Klebsiella Infections (Infectious Disease) - Drugs in Development, 2021
Klebsiella Infections (Infectious Disease) - Drugs in Development, 2021 Summary Klebsiella Infections (Infectious Disease) - Drugs in Development, 2...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Relapsed Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021
Relapsed Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021 Summary Relapsed Chronic Lymphocytic Leukemia (CLL) (Oncology) -...
Published: Apr-2021 | No. of Pages: 170
|
$ 2000 | |
| Calcium/Calmodulin Dependent Protein Kinase Type II (CAMK2 or EC 2.7.11.17) - Drugs in Development, 2021
Calcium/Calmodulin Dependent Protein Kinase Type II (CAMK2 or EC 2.7.11.17) - Drugs in Development, 2021 Summary Calcium/Calmodulin Dependent Protei...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Cells Expressing Receptor Tyrosine Protein Kinase ERBB 2 (Metastatic Lymph Node Gene 19 Protein or Proto Oncogene Neu or Proto Oncogene C ErbB 2 or Tyrosine Kinase Type Cell Surface Receptor HER2 or p185erbB2 or HER2 or CD340 or ERBB2 or EC 2.7.10.1) - Drugs in Development, 2021
Cells Expressing Receptor Tyrosine Protein Kinase ERBB 2 (Metastatic Lymph Node Gene 19 Protein or Proto Oncogene Neu or Proto Oncogene C ErbB 2 or Ty...
Published: Apr-2021 | No. of Pages: 325
|
$ 3500 | |
| Interleukin 5 (Eosinophil Differentiation Factor or B Cell Differentiation Factor I or T Cell Replacing Factor or IL5) - Drugs in Development, 2021
Interleukin 5 (Eosinophil Differentiation Factor or B Cell Differentiation Factor I or T Cell Replacing Factor or IL5) - Drugs in Development, 2021 S...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Interleukin 12 Receptor (IL12R) - Drugs in Development, 2021
Interleukin 12 Receptor (IL12R) - Drugs in Development, 2021 Summary Interleukin 12 Receptor (IL12R) - Drugs in Development, 2021 provides in depth ...
Published: Apr-2021 | No. of Pages: 45
|
$ 3000 | |
| Protozoal Infection (Infectious Disease) - Drugs in Development, 2021
Protozoal Infection (Infectious Disease) - Drugs in Development, 2021 Summary Protozoal Infection (Infectious Disease) - Drugs in Development, 2021 ...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Relapsed Multiple Myeloma (Oncology) - Drugs in Development, 2021
Relapsed Multiple Myeloma (Oncology) - Drugs in Development, 2021 Summary Relapsed Multiple Myeloma (Oncology) - Drugs in Development, 2021 provides...
Published: Apr-2021 | No. of Pages: 425
|
$ 2500 | |
| Caspase 1 (Interleukin 1 Beta Convertase or Interleukin 1 Beta Converting Enzyme or p45 or CASP1 or EC 3.4.22.36) - Drugs in Development, 2021
Caspase 1 (Interleukin 1 Beta Convertase or Interleukin 1 Beta Converting Enzyme or p45 or CASP1 or EC 3.4.22.36) - Drugs in Development, 2021 Summar...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Mu Type Opioid Receptor (MOR1 or Mu Opiate Receptor or Mu Opioid Receptor or OPRM1) - Drugs in Development, 2021
Mu Type Opioid Receptor (MOR1 or Mu Opiate Receptor or Mu Opioid Receptor or OPRM1) - Drugs in Development, 2021 Summary Mu Type Opioid Receptor (MO...
Published: Apr-2021 | No. of Pages: 325
|
$ 3500 |